trial · primary record
Calderasib
Non-small Cell Lung Cancer
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 675 |
| Primary completion | 2032-08-06 |
| Primary endpoint | Progression Free Survival (PFS) in Participants with Programmed Death-Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥1% |
| Registry ID | NCT07190248 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T03:27:36.103Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07190248
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.